Atlas Trials

Evaluation of Safety and Efficacy of RZL-012 in Subjects Seeking Fat Reduction in the Flanks

Clinical trial NCT05445557 · COMPLETED

Trial details

NCT number
NCT05445557
Sponsor
Raziel Therapeutics Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Flank Mass
Start date
2022-03-10
Primary completion
2022-10-20
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.